how to make coin crypto Overview

Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Shenzhen Holdings: Auditor replacement: PricewaterhouseCoopers resigned and Ernst & Young took over. On December 10th, Shenzhen Holdings (00604.HK) announced that according to Rule 13.51(4) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, PricewaterhouseCoopers agreed to resign as the auditor of Shenzhen Holdings with effect from December 10th, 2024. At the same time, the board of directors of Shenzhen Holdings decided to appoint Ernst & Young as the new auditor of the company, which will also take effect from December 10, 2024 until the end of the next annual general meeting.Eight-day four-board three-dimensional communication: the company's operation is normal, and the internal and external operating environment has not changed significantly. On December 9, December 10 and December 11, 2024, the company's closing price increase deviated by more than 20% for three consecutive trading days, which belongs to the abnormal fluctuation of stock trading. The company's operation is normal, and the internal and external operating environment has not changed significantly. The Company has no other circumstances that violate the provisions on fair disclosure of information.

Japanese Reuters's short-term non-manufacturing boom judgment index in December is 30, with the previous value of 19; Reuters's short-term judgment index of manufacturing prosperity in December was -1, with the previous value of 5.Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.Ministry of Finance of the Republic of Korea: We will pay close attention to the financial and foreign exchange market trends and take adequate measures to curb excessive fluctuations in the foreign exchange market.

Bank of America: Resume the coverage of Lilly and give it a "buy" rating with a target price of $997.Yuanyuan Communication: The plan being evaluated and negotiated between the company and toy manufacturers does not involve ByteDance, and the results of subsequent negotiations are still uncertain.The General Administration of Market Supervision held an anti-monopoly compliance lecture hall for the automobile industry. On December 11th, the General Administration of Market Supervision held the ninth anti-monopoly compliance lecture hall in Beijing to give lectures on anti-monopoly compliance for the automobile industry. The General Administration of Market Supervision requires the business entities of the automobile industry to compact the responsibility of the anti-monopoly compliance subject, actively regulate business practices, establish and improve the anti-monopoly compliance system, and effectively prevent and stop the occurrence of monopoly behaviors. The General Administration of Market Supervision will continue to pay attention to the competition in the automobile industry, further promote the special anti-monopoly law enforcement actions in the field of people's livelihood, promote the formation of a fairer and more dynamic market environment, and continuously enhance the people's sense of acquisition, happiness and security. (City speaks Newspeak)